| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85739-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85841-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76697-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76596-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-22209-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61806-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52681-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-130SS | |||
| Azide and BSA Free | NBP2-80761 | |||
![Immunohistochemistry-Paraffin: CD90/Thy1 Antibody [NBP1-85739] Staining of human prostate shows strong cytoplasmic positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/antibody/nbp1-85739_rabbit-polyclonal-cd90-thy1-antibody-immunohistochemistry-paraffin-232202413131..jpg "Immunohistochemistry-Paraffin: CD90/Thy1 Antibody [NBP1-85739] Staining of human prostate shows strong cytoplasmic positivity in smooth muscle cells.")
![Immunohistochemistry-Paraffin: CD90/Thy1 Antibody [NBP1-85739] -Staining of human skeletal muscle shows weak positivity in myocytes.](http://images.novusbio.com/fullsize/antibody/nbp1-85739_rabbit-polyclonal-cd90-thy1-antibody-immunohistochemistry-paraffin-2322024131353..jpg)
![Immunohistochemistry-Paraffin: CD90/Thy1 Antibody [NBP1-85739] -Staining of human pancreas shows no positivity in exocrine glandular cells as expected.](http://images.novusbio.com/fullsize/antibody/nbp1-85739_rabbit-polyclonal-cd90-thy1-antibody-immunohistochemistry-paraffin-2322024131447..jpg)
![Immunohistochemistry-Paraffin: OAS3 Antibody [NBP1-85841] - Staining of human kidney shows strong cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/OAS3-Antibody-Immunohistochemistry-Paraffin-NBP1-85841-img0009.jpg "Immunohistochemistry-Paraffin: OAS3 Antibody [NBP1-85841] - Staining of human kidney shows strong cytoplasmic positivity in cells in tubules.")
![Immunohistochemistry-Paraffin: OAS3 Antibody [NBP1-85841] - Staining of human urinary bladder shows moderate cytoplasmic positivity in urothelial cells.](http://images.novusbio.com/fullsize/OAS3-Antibody-Immunohistochemistry-Paraffin-NBP1-85841-img0007.jpg)
![Immunohistochemistry-Paraffin: OAS3 Antibody [NBP1-85841] - Staining of human duodenum shows weak cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/OAS3-Antibody-Immunohistochemistry-Paraffin-NBP1-85841-img0008.jpg)
![Immunohistochemistry-Paraffin: OAS3 Antibody [NBP1-85841] - Staining of human liver shows no positivity in hepatocytes.](http://images.novusbio.com/fullsize/OAS3-Antibody-Immunohistochemistry-Paraffin-NBP1-85841-img0010.jpg)
![Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/nbp1-85841_rabbit-polyclonal-oas3-antibody-2442025932151.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Western Blot Validation in Mouse Tissue Lysate. Loading: 15 ug of lysates per lane. Antibodies: IL-23A/IL-23 P19 NBP1-76697 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-76697-img0006.jpg "Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Western Blot Validation in Mouse Tissue Lysate. Loading: 15 ug of lysates per lane. Antibodies: IL-23A/IL-23 P19 NBP1-76697 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Immunohistochemistry-Paraffin: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Mouse pancreas tissue with IL23 P19 antibody at 2 ug/ml.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Immunohistochemistry-Paraffin-NBP1-76697-img0002.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Mouse pancreas tissue lysate with IL-23 P19antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-76697-img0003.jpg)
![<b>Expression of Tagged Proteins Validation. </b>Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human IL-23 recombinant protein per lane. Antibodies: IL-23A/IL-23 P19 NBP1-76697 (1: 0.25 ug/mL, 2: 0.5 ug/mL, 3: 1 ug/mL and 4: 2ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-76697-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-76697] - Validation of IL-23A/IL-23 P19 in Mouse Pancreas Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse pancreas tissue labeling IL-23A/IL-23 P19 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-76697_rabbit-polyclonal-il-23a-il-23-p19-antibody-271120241954152.jpg)
![Western Blot: BTK Antibody [NBP1-76596] - Analysis of BTK in U937 cell lysate with anti-BTK using NBP1-76596 at (A) 0.5, (B) 1, and (C) 2 ug/ml.](http://images.novusbio.com/fullsize/BTK-Antibody-Western-Blot-NBP1-76596-img0003.jpg "Western Blot: BTK Antibody [NBP1-76596] - Analysis of BTK in U937 cell lysate with anti-BTK using NBP1-76596 at (A) 0.5, (B) 1, and (C) 2 ug/ml.")
![Immunocytochemistry/Immunofluorescence: BTK Antibody [NBP1-76596] - Daudi cells with BTK antibody at 10 ug/ml.](http://images.novusbio.com/fullsize/BTK-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76596-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: BTK Antibody - BSA Free [NBP1-76596] - Immunofluorescence of BTK in Daudi cells with BTK antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76596_rabbit-polyclonal-btk-antibody-271120242013274.jpg)
![Immunohistochemistry: BTK Antibody - BSA Free [NBP1-76596] - Immunohistochemistry of BTK in mouse brain tissue with BTK antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76596_rabbit-polyclonal-btk-antibody-2711202419432290.gif)
![Immunocytochemistry/ Immunofluorescence: BTK Antibody - BSA Free [NBP1-76596] - Immunofluorescence of BTK in mouse brain tissue with BTK antibody at 20 ug/ml.Red: BTK Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-76596_rabbit-polyclonal-btk-antibody-2711202420352430.gif)
![Western Blot: JNK1 Antibody (1E5) [NBP2-22209] - Western blot analysis using JNK1 mouse mAb against A431 (1), K562 (2), HeLa (3), NIH3T3 (4), PC-12 (5), and MCF-7 (6) cell lysate.](http://images.novusbio.com/fullsize/JNK1-Antibody-1E5-Western-Blot-NBP2-22209-img0004.jpg "Western Blot: JNK1 Antibody (1E5) [NBP2-22209] - Western blot analysis using JNK1 mouse mAb against A431 (1), K562 (2), HeLa (3), NIH3T3 (4), PC-12 (5), and MCF-7 (6) cell lysate.")
![Flow Cytometry: JNK1 Antibody (1E5) [NBP2-22209] - Flow cytometric analysis of HeLa cells using JNK1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/JNK1-Antibody-1E5-Flow-Cytometry-NBP2-22209-img0001.jpg)
![Western Blot: JNK1 Antibody (1E5) [NBP2-22209] - Western blot analysis using MAPK8 mAb against human JNK1 (AA: 227-380) recombinant protein. (Expected MW is 43.4 kDa)](http://images.novusbio.com/fullsize/JNK1-Antibody-1E5-Western-Blot-NBP2-22209-img0003.jpg)
![ELISA: JNK1 Antibody (1E5) [NBP2-22209] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng)](http://images.novusbio.com/fullsize/JNK1-Antibody-1E5-ELISA-NBP2-22209-img0002.jpg)
![Western Blot: ACTR3 Antibody (3G2C9) [NBP2-61806] - Analysis using ACTR3 mAb against HEK293 (1) and ACTR3 (AA: 287-418)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/ACTR3-Antibody-3G2C9-Western-Blot-NBP2-61806-img0005.jpg "Western Blot: ACTR3 Antibody (3G2C9) [NBP2-61806] - Analysis using ACTR3 mAb against HEK293 (1) and ACTR3 (AA: 287-418)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry-Paraffin: ACTR3 Antibody (3G2C9) [NBP2-61806] - Analysis of cervical cancer tissues using ACTR3 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/ACTR3-Antibody-3G2C9-Immunohistochemistry-NBP2-61806-img0003.jpg)
![Western Blot: ACTR3 Antibody (3G2C9) [NBP2-61806] - Analysis using ACTR3 mAb against human ACTR3 (AA: 287-418) recombinant protein. (Expected MW is 41.1 kDa)](http://images.novusbio.com/fullsize/ACTR3-Antibody-3G2C9-Western-Blot-NBP2-61806-img0004.jpg)
![Western Blot: ACTR3 Antibody (3G2C9) [NBP2-61806] - Analysis using ACTR3 mouse mAb against NIH/3T3 (1) and A549 (2) cell lysate.](http://images.novusbio.com/fullsize/ACTR3-Antibody-3G2C9-Western-Blot-NBP2-61806-img0006.jpg)
![ELISA: ACTR3 Antibody (3G2C9) [NBP2-61806] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/ACTR3-Antibody-3G2C9-ELISA-NBP2-61806-img0001.jpg)
![ELISA: ACTR3 Antibody (3G2C9) [NBP2-61806] - Analysis of Hela cells using ACTR3 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/ACTR3-Antibody-3G2C9-ELISA-NBP2-61806-img0002.jpg)
![Western Blot: IGF-II R/Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238) [NB500-464] - Fig. 1. Western Blotting analysis (non-reducing conditions) of CD222 in whole cell lysate of JURKAT human peripheral blood T cell leukemia cell line. Lane 1: immunostaining with anti-CD222 (MEM-238) Lane 2: immunostaining with Isotype mouse IgG1 control (PPV-06).](http://images.novusbio.com/fullsize/IGF-II-R-Mannose-6-Phosphate-Receptor-Cation-independent-Antibody-MEM-238-Western-Blot-NB500-464-img0001.jpg "Western Blot: IGF-II R/Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238) [NB500-464] - Fig. 1. Western Blotting analysis (non-reducing conditions) of CD222 in whole cell lysate of JURKAT human peripheral blood T cell leukemia cell line. Lane 1: immunostaining with anti-CD222 (MEM-238) Lane 2: immunostaining with Isotype mouse IgG1 control (PPV-06).")
![Flow Cytometry: IGF-II R/Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238) [NB500-464] - Flow Cytometry: IGF-II R/Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238) [FITC] [NB100-63599] - Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238)[NB100-63599]- Staining human peripheral blood monocytes following permeablisation with Leucoperm (Fix & Perm) (BUF09). Image using the FITC form of this antibody.](http://images.novusbio.com/fullsize/IGF-II-R-Mannose-6-Phosphate-Receptor-Cation-independent-Antibody-MEM-238-Flow-Cytometry-NB500-464-img0004.jpg)
![Flow Cytometry: IGF-II R/Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238) [NB500-464] - Intracellular staining of human peripheral blood with anti-CD222 (MEM-238) PE.](http://images.novusbio.com/fullsize/IGF-II-R-Mannose-6-Phosphate-Receptor-Cation-independent-Antibody-MEM-238-Flow-Cytometry-NB500-464-img0002.jpg)
![Flow Cytometry: IGF-II R/Mannose 6 Phosphate Receptor (Cation independent) Antibody (MEM-238) [NB500-464] - Surface staining of human peripheral blood with anti-CD222 (MEM-238) biotin, streptavidin-APC](http://images.novusbio.com/fullsize/IGF-II-R-Mannose-6-Phosphate-Receptor-Cation-independent-Antibody-MEM-238-Flow-Cytometry-NB500-464-img0003.jpg)
![Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Brain, Amygdala](http://images.novusbio.com/fullsize/CCR11-Antibody-Immunohistochemistry-Paraffin-NLS1441-img0009.jpg "Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Brain, Amygdala")
![Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Analysis of anti-ACKR4 / CCRL1 / CCR11 antibody with human colon, carcinoma.](http://images.novusbio.com/fullsize/CCR11-Antibody-Immunohistochemistry-Paraffin-NLS1441-img0004.jpg)
![Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Anti-CCRL1 antibody IHC of human heart, cardiac myocytes. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CCR11-Antibody-Immunohistochemistry-Paraffin-NLS1441-img0006.jpg)
![Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Anti-ACKR4 / CCRL1 / CCR11 antibody IHC of human Skin, Melanoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CCR11-Antibody-Immunohistochemistry-Paraffin-NLS1441-img0005.jpg)
![Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Brain, Alzheimer's disease neurofibrillary tangle](http://images.novusbio.com/fullsize/CCR11-Antibody-Immunohistochemistry-Paraffin-NLS1441-img0007.jpg)
![Immunohistochemistry-Paraffin: CCR11 Antibody [NLS1441] - Brain, Alzheimer's disease senile plaque](http://images.novusbio.com/fullsize/CCR11-Antibody-Immunohistochemistry-Paraffin-NLS1441-img0008.jpg)
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with transfected cells expressing CCR7 at 14 ug/ ml.](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0008.jpg "Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with transfected cells expressing CCR7 at 14 ug/ ml.")
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with transfection control at 14 ug/ml.](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0002.jpg)
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with human tonsil at dilution: 14 ug/ml](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0007.jpg)
![Immunohistochemistry-Paraffin: CCR7 Antibody [NLS848] - Analysis of anti-CCR7 antibody with human spleen at dilution 14 ug/ml.](http://images.novusbio.com/fullsize/CCR7-Antibody-Immunohistochemistry-Paraffin-NLS848-img0006.jpg)
![Western Blot: RelA/NFkB p65 Antibody (PSH0-27) [NBP3-32648] - Western blot analysis of RelA/NFkB p65 on different lysates with Rabbit anti-RelA/NFkB p65 antibody (NBP3-32648) at 1/500 dilution. Lane 1: Hela cell lysate (control) Lane 2: Hela-RELA-KO (1) Lane 3: Hela-RELA-KO (2) Lysates/proteins at 35 ug/Lane. Predicted band size: 60 kDa Observed band size: 65 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32648) at 1/500 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:200,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32648_rabbit-rela-nfkb-p65-mab-psh0-27-278202415212453.jpg "Western Blot: RelA/NFkB p65 Antibody (PSH0-27) [NBP3-32648] - Western blot analysis of RelA/NFkB p65 on different lysates with Rabbit anti-RelA/NFkB p65 antibody (NBP3-32648) at 1/500 dilution. Lane 1: Hela cell lysate (control) Lane 2: Hela-RELA-KO (1) Lane 3: Hela-RELA-KO (2) Lysates/proteins at 35 ug/Lane. Predicted band size: 60 kDa Observed band size: 65 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32648) at 1/500 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:200,000 dilution was used for 1 hour at room temperature.")
![Immunohistochemistry: RelA/NFkB p65 Antibody (PSH0-27) [NBP3-32648] - Immunohistochemical analysis of paraffin-embedded human breast tissue with Rabbit anti-RelA/NFkB p65 antibody (NBP3-32648) at 1/1,000 dilution. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (NBP3-32648) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/nbp3-32648_rabbit-rela-nfkb-p65-mab-psh0-27-29820241435276.jpg)
![Immunocytochemistry/ Immunofluorescence: RelA/NFkB p65 Antibody (PSH0-27) [NBP3-32648] - Immunocytochemistry analysis of NIH/3T3 cells treated with or without 50μg/mL TNF-alpha for 20 minutes labeling RelA/NFkB p65 with Rabbit anti-RelA/NFkB p65 antibody (NBP3-32648) at 1/200 dilution. Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-RelA/NFkB p65 antibody (NBP3-32648) at 1/200 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.](http://images.novusbio.com/fullsize/nbp3-32648_rabbit-rela-nfkb-p65-mab-psh0-27-29202410484811.jpg)
![Flow Cytometry: RelA/NFkB p65 Antibody (PSH0-27) [NBP3-32648] - Flow cytometric analysis of NIH/3T3 cells labeling RelA/NFkB p65. Cells were fixed and permeabilized. Then stained with the primary antibody (NBP3-32648, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/nbp3-32648_rabbit-rela-nfkb-p65-mab-psh0-27-2920241637214.jpg)
![Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Flow-Cytometry-NBP2-52681-img0001.jpg "Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: HIF-1 alpha Antibody (H1alpha 67-7) [NB100-130] - HIF-1 alpha in 1: Cos7 CoCl2 treated cells. 2: Untreated cells.](http://images.novusbio.com/fullsize/HIF-1-alpha-Antibody-H1alpha-67-7-Western-Blot-NB100-130-img0001.jpg "<b>Biological Strategies Validation. </b>Western Blot: HIF-1 alpha Antibody (H1alpha 67-7) [NB100-130] - HIF-1 alpha in 1: Cos7 CoCl2 treated cells. 2: Untreated cells.")